CASDIN CAPITAL, LLC – Sarepta Therapeutics, Inc. Transaction History
CASDIN CAPITAL, LLC portfolio value:
$135.41M
portfolio value
CASDIN CAPITAL, LLC quarter portfolio value change:
+47.47%
quarter
Sarepta Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +88.46% | 575K shares | 86.68M | $110.54 | 1.22M |
Q2 2022 | share | Decrease | -18.75% | -150K shares | -13.77M | $74.96 | 650K |
Q1 2022 | share | Decrease | -40.74% | -550K shares | -59.07M | $78.12 | 800K |
Q4 2021 | share | Increase | +22.73% | 250K shares | 19.84M | $90.59 | 1.35M |
Q3 2021 | share | Increase | +24.29% | 215K shares | 32.92M | $92.48 | 1.1M |
Q2 2021 | share | Increase | +60.91% | 335K shares | 27.80M | $77.74 | 885K |
Q1 2021 | share | Increase | +3.77% | 20K shares | -49.36M | $74.53 | 550K |
Q4 2020 | share | 0.00% | 0 shares | 15.93M | $170.49 | 530K | |
Q3 2020 | share | 0.00% | 0 shares | -10.55M | $140.43 | 530K | |
Q2 2020 | share | Decrease | -20.90% | -140K shares | 19.44M | $160.34 | 530K |
Q1 2020 | share | 0.00% | 0 shares | -20.91M | $97.82 | 670K | |
Q4 2019 | share | Decrease | -23.86% | -210K shares | 20.17M | $129.04 | 670K |
Q3 2019 | share | Increase | +162.69% | 545K shares | 15.37M | $75.32 | 880K |
Q2 2019 | share | Increase | +9.84% | 30K shares | 14.55M | $151.95 | 335K |
Q1 2019 | share | Increase | +103.33% | 155K shares | 19.98M | $119.19 | 305K |
Q4 2018 | share | Increase | +275.00% | 110K shares | 9.91M | $109.13 | 150K |
Q3 2018 | share | Increase | 0.00% | 40K shares | 6.46M | $161.51 | 40K |